PharmEasy raises $350 million in Pre-IPO round at $5.6 billion valuation
PharmEasy has reportedly secured $350 million (~Rs. 2,600 crore) in the Pre-IPO funding round at a $5.6 billion valuation.
Source: techstory.in
Stay updated with breaking news from Dhramil Sheth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PharmEasy has reportedly secured $350 million (~Rs. 2,600 crore) in the Pre-IPO funding round at a $5.6 billion valuation.
IPO-Bound PharmEasy which is set to file its DRHP this month has scooped up $350 Mn in a primary as well as secondary round.
API Holdings Ltd, the parent of PharmEasy, has also closed a $130-140 million secondary share sale. Around 20 senior executives have acquired shares worth $5 million as part of the secondary sale